Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 243,765 | 879 | N/A | N/A | N/A |
| TOTAL | $255,601 | $902 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 463 | 0 | N/A | N/A | N/A |
| Other Non-Current Assets | 1,114 | 0 | 0 | 0 | 0 |
| TOTAL | $1,577 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $257,178 | $902 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,950 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 699 | 55 | 0 | 0 | 0 |
| Accrued Expenses | 2,475 | 183 | N/A | N/A | N/A |
| Other current liabilities | 413 | N/A | N/A | N/A | N/A |
| TOTAL | $3,748 | $2,188 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,777 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 2,698 | 0 | 0 | 0 | 0 |
| TOTAL | $25,475 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $29,223 | $2,188 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,965 | N/A | N/A | N/A | N/A |
| Common Shares | 2 | N/A | N/A | N/A | N/A |
| Retained earnings | -256,419 | -1,288 | N/A | N/A | N/A |
| TOTAL | $227,955 | $-1,286 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $257,178 | $902 | $0 | $0 | $0 |